{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T01:10:02Z","timestamp":1775005802519,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T00:00:00Z","timestamp":1400025600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s11255-014-0737-7","type":"journal-article","created":{"date-parts":[[2014,5,13]],"date-time":"2014-05-13T12:47:23Z","timestamp":1399985243000},"page":"1733-1736","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Hydroxyurea therapy for priapism prevention and erectile function recovery in sickle cell disease: a case report and review of the literature"],"prefix":"10.1007","volume":"46","author":[{"given":"Uzoma A.","family":"Anele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kyle Mack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda M. S.","family":"Resar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur L.","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,14]]},"reference":[{"issue":"4 Pt 1","key":"737_CR1","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1097\/01.ju.0000087608.07371.ca","volume":"170","author":"DK Montague","year":"2003","unstructured":"Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, Nehra A, Sharlip ID, Members of the Erectile Dysfunction Guideline Update P, American Urological A (2003) American Urological Association guideline on the management of priapism. J Urol 170(4 Pt 1):1318\u20131324. doi: 10.1097\/01.ju.0000087608.07371.ca","journal-title":"J Urol"},{"issue":"1","key":"737_CR2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1743-6109.2011.02288.x","volume":"9","author":"TJ Bivalacqua","year":"2012","unstructured":"Bivalacqua TJ, Musicki B, Kutlu O, Burnett AL (2012) New insights into the pathophysiology of sickle cell disease-associated priapism. J Sex Med 9(1):79\u201387. doi: 10.1111\/j.1743-6109.2011.02288.x","journal-title":"J Sex Med"},{"issue":"5","key":"737_CR3","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.0407183102","volume":"102","author":"HC Champion","year":"2005","unstructured":"Champion HC, Bivalacqua TJ, Takimoto E, Kass DA, Burnett AL (2005) Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proc Natl Acad Sci USA 102(5):1661\u20131666. doi: 10.1073\/pnas.0407183102","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"737_CR4","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1111\/j.1743-6109.2010.02062.x","volume":"7","author":"F Montorsi","year":"2010","unstructured":"Montorsi F, Adaikan G, Becher E, Giuliano F, Khoury S, Lue TF, Sharlip I, Althof SE, Andersson KE, Brock G, Broderick G, Burnett A, Buvat J, Dean J, Donatucci C, Eardley I, Fugl-Meyer KS, Goldstein I, Hackett G, Hatzichristou D, Hellstrom W, Incrocci L, Jackson G, Kadioglu A, Levine L, Lewis RW, Maggi M, McCabe M, McMahon CG, Montague D, Montorsi P, Mulhall J, Pfaus J, Porst H, Ralph D, Rosen R, Rowland D, Sadeghi-Nejad H, Shabsigh R, Stief C, Vardi Y, Wallen K, Wasserman M (2010) Summary of the recommendations on sexual dysfunctions in men. J Sex Med 7(11):3572\u20133588. doi: 10.1111\/j.1743-6109.2010.02062.x","journal-title":"J Sex Med"},{"issue":"1","key":"737_CR5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.juro.2013.07.034","volume":"191","author":"E Zacharakis","year":"2014","unstructured":"Zacharakis E, Raheem AA, Freeman A, Skolarikos A, Garaffa G, Christopher AN, Muneer A, Ralph DJ (2014) The efficacy of the T-shunt procedure and intracavernous tunneling (snake maneuver) for refractory ischemic priapism. J Urol 191(1):164\u2013168. doi: 10.1016\/j.juro.2013.07.034","journal-title":"J Urol"},{"issue":"5","key":"737_CR6","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1097\/00005392-199805000-00065","volume":"159","author":"AH Al Jam\u2019a","year":"1998","unstructured":"Al Jam\u2019a AH, Al Dabbous IA (1998) Hydroxyurea in the treatment of sickle cell associated priapism. J Urol 159(5):1642. doi: 10.1097\/00005392-199805000-00065","journal-title":"J Urol"},{"issue":"1","key":"737_CR7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ajh.20142","volume":"77","author":"ST Saad","year":"2004","unstructured":"Saad ST, Lajolo C, Gilli S, Marques Junior JF, Lima CS, Costa FF, Arruda VR (2004) Follow-up of sickle cell disease patients with priapism treated by hydroxyurea. Am J Hematol 77(1):45\u201349. doi: 10.1002\/ajh.20142","journal-title":"Am J Hematol"},{"issue":"2","key":"737_CR8","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1046\/j.1365-2141.2002.03274.x","volume":"116","author":"MT Gladwin","year":"2002","unstructured":"Gladwin MT, Shelhamer JH, Ognibene FP, Pease-Fye ME, Nichols JS, Link B, Patel DB, Jankowski MA, Pannell LK, Schechter AN, Rodgers GP (2002) Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease. Br J Haematol 116(2):436\u2013444","journal-title":"Br J Haematol"},{"issue":"1","key":"737_CR9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1182\/blood-2005-11-4454","volume":"108","author":"VP Cokic","year":"2006","unstructured":"Cokic VP, Beleslin-Cokic BB, Tomic M, Stojilkovic SS, Noguchi CT, Schechter AN (2006) Hydroxyurea induces the eNOS-cGMP pathway in endothelial cells. Blood 108(1):184\u2013191. doi: 10.1182\/blood-2005-11-4454","journal-title":"Blood"},{"issue":"1","key":"737_CR10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1096\/fj.13-228817","volume":"28","author":"G Lagoda","year":"2014","unstructured":"Lagoda G, Sezen SF, Hurt KJ, Cabrini MR, Mohanty DK, Burnett AL (2014) Sustained nitric oxide (NO)-releasing compound reverses dysregulated NO signal transduction in priapism. FASEB J 28(1):76\u201384. doi: 10.1096\/fj.13-228817","journal-title":"FASEB J"},{"issue":"3","key":"737_CR11","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/jcp.22195","volume":"224","author":"I Akinsheye","year":"2010","unstructured":"Akinsheye I, Klings ES (2010) Sickle cell anemia and vascular dysfunction: the nitric oxide connection. J Cell Physiol 224(3):620\u2013625. doi: 10.1002\/jcp.22195","journal-title":"J Cell Physiol"},{"issue":"12","key":"737_CR12","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nm1202-799","volume":"8","author":"CD Reiter","year":"2002","unstructured":"Reiter CD, Wang X, Tanus-Santos JE, Hogg N, Cannon RO 3rd, Schechter AN, Gladwin MT (2002) Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 8(12):1383\u20131389. doi: 10.1038\/nm799","journal-title":"Nat Med"},{"issue":"26","key":"737_CR13","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1182\/blood-2009-04-146852","volume":"115","author":"RE Ware","year":"2010","unstructured":"Ware RE (2010) How I use hydroxyurea to treat young patients with sickle cell anemia. Blood 115(26):5300\u20135311. doi: 10.1182\/blood-2009-04-146852","journal-title":"Blood"},{"issue":"6","key":"737_CR14","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1172\/JCI118925","volume":"98","author":"DC Rockey","year":"1996","unstructured":"Rockey DC, Chung JJ (1996) Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing. J Clin Invest 98(6):1381\u20131388. doi: 10.1172\/JCI118925","journal-title":"J Clin Invest"},{"issue":"6","key":"737_CR15","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1091\/mbc.E03-12-0902","volume":"15","author":"X Shi-Wen","year":"2004","unstructured":"Shi-Wen X, Chen Y, Denton CP, Eastwood M, Renzoni EA, Bou-Gharios G, Pearson JD, Dashwood M, du Bois RM, Black CM, Leask A, Abraham DJ (2004) Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac\/phosphoinositide 3-kinase\/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. Mol Biol Cell 15(6):2707\u20132719. doi: 10.1091\/mbc.E03-12-0902","journal-title":"Mol Biol Cell"},{"issue":"2","key":"737_CR16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12185-013-1392-y","volume":"98","author":"ES Hatzipantelis","year":"2013","unstructured":"Hatzipantelis ES, Pana ZD, Gombakis N, Taparkou A, Tzimouli V, Kleta D, Zafeiriou DJ, Garipidou V, Kanakoudi F, Athanassiou M (2013) Endothelial activation and inflammation biomarkers in children and adolescents with sickle cell disease. Int J Hematol 98(2):158\u2013163. doi: 10.1007\/s12185-013-1392-y","journal-title":"Int J Hematol"},{"issue":"7","key":"737_CR17","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1182\/blood.V92.7.2594","volume":"92","author":"AC Rybicki","year":"1998","unstructured":"Rybicki AC, Benjamin LJ (1998) Increased levels of endothelin-1 in plasma of sickle cell anemia patients. Blood 92(7):2594\u20132596","journal-title":"Blood"},{"issue":"4","key":"737_CR18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/sj.tpj.6500176","volume":"3","author":"M Brun","year":"2003","unstructured":"Brun M, Bourdoulous S, Couraud PO, Elion J, Krishnamoorthy R, Lapoumeroulie C (2003) Hydroxyurea downregulates endothelin-1 gene expression and upregulates ICAM-1 gene expression in cultured human endothelial cells. Pharmacogenomics J 3(4):215\u2013226. doi: 10.1038\/sj.tpj.6500176","journal-title":"Pharmacogenomics J"},{"issue":"3","key":"737_CR19","first-page":"401","volume":"90","author":"C Lapoumeroulie","year":"2005","unstructured":"Lapoumeroulie C, Benkerrou M, Odievre MH, Ducrocq R, Brun M, Elion J (2005) Decreased plasma endothelin-1 levels in children with sickle cell disease treated with hydroxyurea. Haematologica 90(3):401\u2013403","journal-title":"Haematologica"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-014-0737-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-014-0737-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-014-0737-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T10:03:31Z","timestamp":1597831411000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-014-0737-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,14]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["737"],"URL":"https:\/\/doi.org\/10.1007\/s11255-014-0737-7","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,14]]}}}